Written Question·Department of Health and Social Care·UIN 101536
Tirzepatide
Tabled: 18 December 2025
Answered: 5 January 2026
Question
Tom Morrison
Liberal Democrat — Cheadle
To ask the Secretary of State for Health and Social Care, what assessment they have made of variations in access to Tirzepatide (Mounjaro) across Integrated Care Boards; and what steps they are taking to ensure consistency in prescribing for eligible pati
Answer
Dr Zubir AhmedTirzepatide, brand name Mounjaro, is recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of both type 2 diabetes and obesity.Integrated care boards (ICBs) are legally required to fund NICE-recommended medicines, i...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 101536) →